IL161262A0 - Storage-stable human fibrinogen solutions - Google Patents

Storage-stable human fibrinogen solutions

Info

Publication number
IL161262A0
IL161262A0 IL16126202A IL16126202A IL161262A0 IL 161262 A0 IL161262 A0 IL 161262A0 IL 16126202 A IL16126202 A IL 16126202A IL 16126202 A IL16126202 A IL 16126202A IL 161262 A0 IL161262 A0 IL 161262A0
Authority
IL
Israel
Prior art keywords
storage
human fibrinogen
stable human
fibrinogen solutions
solutions
Prior art date
Application number
IL16126202A
Other languages
English (en)
Original Assignee
Christopher J Woolverton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christopher J Woolverton filed Critical Christopher J Woolverton
Publication of IL161262A0 publication Critical patent/IL161262A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL16126202A 2001-10-03 2002-10-03 Storage-stable human fibrinogen solutions IL161262A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32696201P 2001-10-03 2001-10-03
PCT/US2002/031431 WO2003028654A2 (en) 2001-10-03 2002-10-03 Storage-stable human fibrinogen solutions

Publications (1)

Publication Number Publication Date
IL161262A0 true IL161262A0 (en) 2004-09-27

Family

ID=23274522

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16126202A IL161262A0 (en) 2001-10-03 2002-10-03 Storage-stable human fibrinogen solutions

Country Status (9)

Country Link
US (1) US20030091559A1 (de)
EP (1) EP1439846A4 (de)
JP (1) JP2005505581A (de)
KR (1) KR20040055782A (de)
CN (1) CN1599616A (de)
AU (1) AU2002348491A1 (de)
CA (1) CA2462596A1 (de)
IL (1) IL161262A0 (de)
WO (1) WO2003028654A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
CN101851339B (zh) * 2010-05-19 2011-10-26 成都新际生物活性胶原开发有限公司 一种驴皮胶原的制备方法
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
EP3366301A1 (de) * 2012-05-14 2018-08-29 Teijin Limited Strahlungssterilisierungsbeständige proteinzusammensetzung
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
CN110988367B (zh) * 2019-11-18 2024-02-09 迈克生物股份有限公司 一种贮存剂、用于检测lh的校准品及检测试剂盒
WO2021099582A1 (en) * 2019-11-22 2021-05-27 Sorbonne Universite Process for the preparation of fibrinogen-based materials and fibrinogen-based materials obtained by said process
US12030918B2 (en) * 2019-12-06 2024-07-09 University Of Wyoming Fibrin particles and methods of forming fibrin particles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
DE3175003D1 (en) * 1981-06-25 1986-08-28 Serapharm Gmbh & Co Kg Enriched plasma derivative for promoting wound sealing and wound healing
US4928603A (en) * 1984-09-07 1990-05-29 The Trustees Of Columbia University In The City Of New York Method of preparing a cryoprecipitated suspension and use thereof
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US4714457A (en) * 1986-09-15 1987-12-22 Robert Alterbaum Method and apparatus for use in preparation of fibrinogen from a patient's blood
DE3722904A1 (de) * 1987-01-09 1988-07-21 Harald Maslanka Injektionseinrichtung mit doppelkanuele fuer ein endoskop
ES2006632A6 (es) * 1987-04-21 1989-05-01 Green Cross Corp Procedimiento de tratamiento termico de fibrinogeno.
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
JP3867931B2 (ja) * 1993-11-08 2007-01-17 財団法人化学及血清療法研究所 液状フィブリノゲン製剤
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
FR2757770B1 (fr) * 1996-12-30 1999-02-26 Inoteb Procede de preparation d'une colle biologique capable de coaguler par simple addition d'ions calcium
CA2395431C (en) * 1999-12-23 2010-08-17 Csl Limited Separation of fibrinogen from plasma proteases

Also Published As

Publication number Publication date
CN1599616A (zh) 2005-03-23
WO2003028654A2 (en) 2003-04-10
EP1439846A4 (de) 2005-09-28
CA2462596A1 (en) 2003-04-10
EP1439846A2 (de) 2004-07-28
WO2003028654A3 (en) 2004-01-29
AU2002348491A1 (en) 2003-04-14
JP2005505581A (ja) 2005-02-24
US20030091559A1 (en) 2003-05-15
KR20040055782A (ko) 2004-06-26

Similar Documents

Publication Publication Date Title
GB0106560D0 (en) Perfume encapsulates
IL162369A0 (en) Storage-stable fibrin sealant
HK1049445A1 (zh) 牙粉
IL161261A0 (en) Storage-stable fibrinogen solutions
MXPA03006629A (es) Composicion para el cuidado de la piel.
IL161262A0 (en) Storage-stable human fibrinogen solutions
GB0211962D0 (en) Irrigator
EP1394120A4 (de) Desinfektionsmittel
GB0030541D0 (en) Medical uses
GB0125492D0 (en) Formulation
GB0209356D0 (en) Medical facemask
GB2396812B (en) Formulation
GB2375048B (en) Formulation
DE60231474D1 (en) Monitor
AU2002348493A1 (en) Storage-stable fibrinogen solutions
GB0122717D0 (en) Disposable insole
GB0116619D0 (en) Formulation
GB0118830D0 (en) Disinfectant formulation
GB0121452D0 (en) Disinfectant formulation
GB0112497D0 (en) Formulation
EG23586A (en) Haemagel solution
TWI315313B (en) Human coagulation factor vii variants
AU148169S (en) Cot
AU148103S (en) Tissue
AU145797S (en) Medical dressing